FOLFIRINOX in first-line metastatic pancreatic cancer regimen (FLMPC): What profile of patients take a real advantage? Real world cohort from cancer observatory from Brittany and Pays de la Loire areas.
Jean-Philippe Metges
No relevant relationships to disclose
Jean François Ramée
No relevant relationships to disclose
Roger Faroux
No relevant relationships to disclose
Jean-Yves Douillard
No relevant relationships to disclose
Marc Porneuf
No relevant relationships to disclose
Isabelle Cumin
No relevant relationships to disclose
Pierre-Luc Etienne
No relevant relationships to disclose
Alain Gourlaouen
No relevant relationships to disclose
Guillaume Geslin
No relevant relationships to disclose
Nacredine Achour
No relevant relationships to disclose
Patrick Soulie
No relevant relationships to disclose
Gerard Le Bihan
No relevant relationships to disclose
Catherine Le Roux
No relevant relationships to disclose
Laurent Miglianico
No relevant relationships to disclose
Philippe Deguiral
No relevant relationships to disclose
Christian Riche
No relevant relationships to disclose
Fanny Marhuenda
No relevant relationships to disclose
Delphine Deniel Lagadec
No relevant relationships to disclose
Loic Campion
No relevant relationships to disclose
Francoise Grude
No relevant relationships to disclose